Responses
Regular and young investigator award abstracts
Biomarkers, immune monitoring, and novel technologies
87 Transcription factor RUNX1 activates OPN to promote tumor progression via MAPK signaling in head and neck cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.
